These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

673 related items for PubMed ID: 14979885

  • 1. Treatment of primary headache disorders with intravenous valproate: initial outpatient experience.
    Stillman MJ, Zajac D, Rybicki LA.
    Headache; 2004 Jan; 44(1):65-9. PubMed ID: 14979885
    [Abstract] [Full Text] [Related]

  • 2. Intravenous sodium valproate versus prochlorperazine for the emergency department treatment of acute migraine headaches: a prospective, randomized, double-blind trial.
    Tanen DA, Miller S, French T, Riffenburgh RH.
    Ann Emerg Med; 2003 Jun; 41(6):847-53. PubMed ID: 12764341
    [Abstract] [Full Text] [Related]

  • 3. Diagnosis of menstrual headache and an open-label study among those with previously undiagnosed menstrually related migraine to evaluate the efficacy of sumatriptan 100 mg.
    Schreiber CP, Cady RK.
    Clin Ther; 2007 Jun; 29 Suppl():2511-9. PubMed ID: 18164918
    [Abstract] [Full Text] [Related]

  • 4. Effect of pain intensity and time to administration on responsiveness to almotriptan: results from AXERT 12.5 mg Time Versus Intensity Migraine Study (AIMS).
    Freitag FG, Finlayson G, Rapoport AM, Elkind AH, Diamond ML, Unger JR, Fisher AC, Armstrong RB, Hulihan JF, Greenberg SJ, AIMS Investigators.
    Headache; 2007 Apr; 47(4):519-30. PubMed ID: 17445101
    [Abstract] [Full Text] [Related]

  • 5. Valdecoxib for treatment of a single, acute, moderate to severe migraine headache.
    Kudrow D, Thomas HM, Ruoff G, Ishkanian G, Sands G, Le VH, Brown MT.
    Headache; 2005 Oct; 45(9):1151-62. PubMed ID: 16178945
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of sumatriptan tablets in migraineurs self-described or physician-diagnosed as having sinus headache: a randomized, double-blind, placebo-controlled study.
    Ishkanian G, Blumenthal H, Webster CJ, Richardson MS, Ames M.
    Clin Ther; 2007 Jan; 29(1):99-109. PubMed ID: 17379050
    [Abstract] [Full Text] [Related]

  • 7. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.
    Dodick DW, Mauskop A, Elkind AH, DeGryse R, Brin MF, Silberstein SD, BOTOX CDH Study Group.
    Headache; 2005 Apr; 45(4):315-24. PubMed ID: 15836567
    [Abstract] [Full Text] [Related]

  • 8. Transformed migraine and medication overuse in a tertiary headache centre--clinical characteristics and treatment outcomes.
    Bigal ME, Rapoport AM, Sheftell FD, Tepper SJ, Lipton RB.
    Cephalalgia; 2004 Jun; 24(6):483-90. PubMed ID: 15154858
    [Abstract] [Full Text] [Related]

  • 9. Single-dose intravenous tramadol for acute migraine pain in adults: a single-blind, prospective, randomized, placebo-controlled clinical trial.
    Alemdar M, Pekdemir M, Selekler HM.
    Clin Ther; 2007 Jul; 29(7):1441-7. PubMed ID: 17825695
    [Abstract] [Full Text] [Related]

  • 10. Sodium valproate in severe migraine and tension-type headache: an open study of long-term efficacy and correlation with blood levels.
    Lenaerts M, Bastings E, Sianard J, Schoenen J.
    Acta Neurol Belg; 1996 Jun; 96(2):126-9. PubMed ID: 8711985
    [Abstract] [Full Text] [Related]

  • 11. Safety and efficacy of intravenous sodium valproate in the treatment of acute migraine.
    Waberzinek G, Marková J, Mastík J.
    Neuro Endocrinol Lett; 2007 Feb; 28(1):59-64. PubMed ID: 17277725
    [Abstract] [Full Text] [Related]

  • 12. Duration of migraine is a predictor for response to botulinum toxin type A.
    Eross EJ, Gladstone JP, Lewis S, Rogers R, Dodick DW.
    Headache; 2005 Apr; 45(4):308-14. PubMed ID: 15836566
    [Abstract] [Full Text] [Related]

  • 13. Oral transmucosal fentanyl citrate for the treatment of migraine headache pain in outpatients: a case series.
    Landy SH.
    Headache; 2004 Sep; 44(8):762-6. PubMed ID: 15330821
    [Abstract] [Full Text] [Related]

  • 14. Prevalence of migraine and response to sumatriptan in patients self-reporting tension/stress headache.
    Kaniecki R, Ruoff G, Smith T, Barrett PS, Ames MH, Byrd S, Kori S.
    Curr Med Res Opin; 2006 Aug; 22(8):1535-44. PubMed ID: 16870078
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and tolerability of intravenous valproic acid in acute adolescent migraine.
    Reiter PD, Nickisch J, Merritt G.
    Headache; 2005 Aug; 45(7):899-903. PubMed ID: 15985107
    [Abstract] [Full Text] [Related]

  • 16. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R, Schreiber C.
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [Abstract] [Full Text] [Related]

  • 17. Predictors of response to botulinum toxin type A (BoNTA) in chronic daily headache.
    Mathew NT, Kailasam J, Meadors L.
    Headache; 2008 Feb; 48(2):194-200. PubMed ID: 17868356
    [Abstract] [Full Text] [Related]

  • 18. Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study.
    Tepper SJ, Cady R, Dodick D, Freitag FG, Hutchinson SL, Twomey C, Kuhn TA.
    Headache; 2006 Jan; 46(1):115-24. PubMed ID: 16412159
    [Abstract] [Full Text] [Related]

  • 19. Individualizing treatment with verapamil for cluster headache patients.
    Blau JN, Engel HO.
    Headache; 2004 Jan; 44(10):1013-8. PubMed ID: 15546265
    [Abstract] [Full Text] [Related]

  • 20. Divalproex sodium in the treatment of migraine and cluster headaches.
    Gallagher RM, Mueller LL, Freitag FG.
    J Am Osteopath Assoc; 2002 Feb; 102(2):92-4. PubMed ID: 11866398
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.